Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Cardiac FailureAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- A history of devices as an alternative to heart transplantation.Heart Fail Clin. 2014; 10: S1-12
- Evolving trends in mechanical circulatory support: clinical development of a fully magnetically levitated durable ventricular assist device.Trends Cardiovasc Med. 2020; 30: 223-229
- Left ventricular assist devices for lifelong support.J Am Coll Cardiol. 2017; 69: 2845-2861
- The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.Health Technol Assess. 2005; 9 (iii–iv): 1-132
- The burden of haemocompatibility with left ventricular assist systems: a complex weave.Eur Heart J. 2019; 40: 673-677
- The vexing problem of thrombosis in long-term mechanical circulatory support.J Heart Lung Transplant. 2014; 33: 1-11
- The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies.JACC Heart Fail. 2015; 3: 818-828
- HVAD: The ENDURANCE Supplemental Trial.JACC Heart Fail. 2018; 6: 792-802
- A fully magnetically levitated circulatory pump for advanced heart failure.N Engl J Med. 2017; 376 (2): 440-450
- A fully magnetically levitated left ventricular assist device - final report.N Engl J Med. 2019; 380: 1618-1627
Medtronic. Medtronic to stop distribution and sale of HVADTM system. Available at: https://newsroom.medtronic.com/news-releases/news-release-details/medtronic-stop-distribution-and-sale-hvadtm-system. Accessed June 8, 2021.
- Evolving disruption in left ventricular assist systems: forgiving but not yet forgettable.Eur J Heart Fail. 2019; 21: 98-100
- Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.Eur J Heart Fail. 2021 May 1; https://doi.org/10.1002/ejhf.2211
- Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - the CLEAR-LVAD study.J Heart Lung Transplant. 2021; 40: 323-333
- Concordance of treatment effect: an analysis of the Society of Thoracic Surgeons INTERMACS database.Ann Thorac Surg. 2021 Jun 1; (S0003-4975(21)00929-2)
- "I need help—a mnemonic to aid timely referral in advanced heart failure.J Heart Lung Transplant. 2017; 36: 593-594
- Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.Eur J Heart Fail. 2017; 19: 595-602
- Transcatheter mitral valve intervention in advanced heart failure.J Heart Lung Transplant. 2020; 39: 1363-1365
- First series of left ventricular assist device exchanges to HeartMate 3.Eur J Cardiothorac Surg. 2017; 51: 887-892
- Left ventricular assist devices: challenges toward sustaining long-term patient care.Ann Biomed Eng. 2017; 45: 1836-1851https://doi.org/10.1007/s10439-017-1858-9
Article info
Publication history
Published online: June 14, 2021
Accepted:
June 9,
2021
Received:
June 9,
2021
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
